Lee Ainslie’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.51M Buy
+6,780
New +$1.58M 0.01% 132
2023
Q3
– Sell
-8,177
Closed -$773K – 336
2023
Q2
$773K Buy
+8,177
New +$691K 0.02% 187
2021
Q4
– Sell
-10,689
Closed -$529K – 367
2021
Q3
$529K Buy
10,689
+10,068
+1,621% +$546K 0.01% 434
2021
Q2
$35K Buy
+621
New +$36.3K ﹤0.01% 635
2021
Q1
– Sell
-13,597
Closed -$728K – 717
2020
Q4
$728K Sell
13,597
-26,486
-66% -$1.37M 0.01% 288
2020
Q3
$1.88M Buy
40,083
+11,874
+42% +$609K 0.04% 151
2020
Q2
$1.47M Sell
28,209
-18,313
-39% -$944K 0.03% 220
2020
Q1
$2.23M Buy
+46,522
New +$2.42M 0.05% 170

Other funds holding CAH

Lee Ainslie's CAH Position: Q3 2026 in Review

Lee Ainslie opened a new position in Cardinal Health (CAH) in Q3 2026: 6,780 shares worth $1.51M. The stake represents 0.01% of the portfolio and ranks #132 among its holdings. This is a return to the name: Lee Ainslie previously reported a position in CAH as recently as Q2 2023.

Lee Ainslie first reported a position in CAH in Q1 2020 and has held it in 8 quarters since. The position peaked at $2.23M in Q1 2020. 1,490 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Lee Ainslie held 6,780 shares of Cardinal Health worth $1.51M as of Q3 2026.
  • Cardinal Health was a new Lee Ainslie position in Q3 2026.
  • Cardinal Health made up 0.01% of Lee Ainslie's portfolio in Q3 2026, its #132 holding.
  • Lee Ainslie first reported a position in Cardinal Health in Q1 2020 and has held it in 8 quarters since.
  • Lee Ainslie's Cardinal Health position peaked at $2.23M in Q1 2020.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.